Literature DB >> 20102957

Behavior of unrepaired perimembranous ventricular septal defect in young adults.

Veerle Soufflet1, Alexander Van de Bruaene, Els Troost, Marc Gewillig, Philip Moons, Martijn C Post, Werner Budts.   

Abstract

The number of adolescents and young adults with congenital heart defects, including ventricular septal defect (VSD), increases continuously. We evaluated the mid-term outcome of small and unclosed perimembranous VSDs (pmVSDs). All patients with a known unrepaired pmVSD at 16 years of age were selected from our database. The clinical, electrocardiographic, and echocardiographic changes between baseline and the latest follow-up examination were compared. A total of 220 patients (119 males, median age 18 years, interquartile range 7) could be included. During a median follow-up of 6 years (interquartile range 4, range 38), 2 patients died (1%; 1 from sudden death and 1 from end-stage heart failure). Endocarditis occurred in 8 patients (4%). One patient required pacemaker implantation (0.5%) and one required implantable cardioverter-defibrillator implantation (1%). Fifteen patients (7%) required a closing procedure. In 8 patients (4%), the pmVSD closed spontaneously. In the remaining 203 patients (93%), the QRS morphology changed in 5% and 1% lost sinus rhythm (p = 0.0001 and p = 0.015, respectively). The left ventricular ejection fraction and stroke volume index increased from 62 + or - 7% to 67 + or - 8% and from 41 + or - 11 to 44 + or - 15 ml/m(2) (p = 0.0001 and p = 0.035, respectively), the end-systolic diameter decreased, and the end-diastolic diameter did not change. Finally, patients with an open pmVSD developed more pulmonary arterial hypertension during follow-up (from 3% to 9%, p = 0.002). In conclusion, mid-term follow-up of adolescents and young adults with a small and unrepaired pmVSD was not uneventful. Some patients required intervention, but in others, spontaneous closure occurred. Electrocardiographic and structural changes were noticed, for which the clinical significance needs to be determined. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 20102957     DOI: 10.1016/j.amjcard.2009.09.047

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

1.  Mechanisms of exercise-induced pulmonary hypertension in patients with cardiac septal defects.

Authors:  Henrik Brun; Thomas Moller; Per M Fredriksen; Erik Thaulow; Are H Pripp; Henrik Holmstrom
Journal:  Pediatr Cardiol       Date:  2012-03-01       Impact factor: 1.655

Review 2.  A review of spontaneous closure of ventricular septal defect.

Authors:  Jun Zhang; Jong Mi Ko; Joseph M Guileyardo; William C Roberts
Journal:  Proc (Bayl Univ Med Cent)       Date:  2015-10

Review 3.  [Interventional closure of atrial septal defects, patent oval foramen and ventricular septal defects].

Authors:  Marius Hornung; Jennifer Franke; Dani Id; Horst Sievert
Journal:  Herz       Date:  2015-08       Impact factor: 1.443

4.  Tricuspid Valve Endocarditis in Four Patients with Unrepaired Restrictive Perimembranous Ventricular Septal Defects.

Authors:  Adam M Butensky; Alexandra Channing; Andrew S Handel; David Kalfa; Stuart Holzer
Journal:  Pediatr Cardiol       Date:  2022-06-03       Impact factor: 1.838

5.  A ventricular septal defect with a giant appendiform aneurysm of the membranous septum.

Authors:  M A Cozijnsen; L Cozijnsen; A C P Maas; M Bakker-de Boo; B J Bouma
Journal:  Neth Heart J       Date:  2013-03       Impact factor: 2.380

6.  Detection of Early Myocardial Injury in Children with Ventricular Septal Defect Using Cardiac Troponin I and Two-Dimensional Speckle Tracking Echocardiography.

Authors:  Alyaa A Kotby; Manal M Abd Al Aziz; Adel H Husseiny; Marwa M Al-Fahham
Journal:  Pediatr Cardiol       Date:  2020-07-12       Impact factor: 1.655

7.  Should we close small ventricular septal defects?

Authors:  Sangeetha Viswanathan; R Krishna Kumar
Journal:  Ann Pediatr Cardiol       Date:  2017 Jan-Apr

8.  The ciliary protein Ftm is required for ventricular wall and septal development.

Authors:  Christoph Gerhardt; Johanna M Lier; Stefanie Kuschel; Ulrich Rüther
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.